Key Points
• Quality assurance encompasses all actions taken to establish, protect, promote and improve the quality of health care.
• Medical genetics services aim to help people with a genetic disadvantage to live and reproduce as normally as possible.
• Health transition has resulted in many middle- and low-income nations developing medical genetic services appropriate to their needs and circumstances.
• Health needs assessment is an objective, epidemiological evidence-based approach to commissioning and planning health services to improve population health.
• To assure quality in establishing of medical genetic services, middle- and low-income nations should consider undertaking health needs assessments.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
A congenital disorder is defined as any abnormality of structure or function, including metabolism, which is present from birth. It is synonymous, and can be used interchangeably, with the term birth defect. Serious congenital disorders are those that are life threatening or have the potential to cause disability.3
- 2.
Complex disorders develop after birth, manifesting in childhood but mostly in mid and later life. They are complex because their aetiology is multifactorial, with the environmental component being mostly postnatal. By comparison with multifactorial congenital disorders (congenital malformations) they are clinically complex, being systemic and involving different organs and systems. They include a wide range of diseases including common disorders like cancer, diabetes, hypertension, mental disorders and stroke.
- 3.
Middle- and low-income nations is the term preferred for so-called “developing” nations. Middle- and low-income nations are defined by the World Bank.
- 4.
The WHO defines a control programme for congenital disorders as encompassing best possible care (diagnosis, treatment and genetic counselling with psychosocial support) available with prevention by community education, preconception care, medical genetic screening, genetic counselling, prenatal diagnosis and associated services. Preconception care, has recently been added to the original definition.
- 5.
Effectiveness is the degree to which possible improvements in health are actually attained (Donnabedian 2003).
References
Alwan A, Modell B. Community control of genetic and congenital disorders. Technical Publication Series 24. WHO Eastern Mediterranean Regional Office. 1997.
Christianson AL, Howson CP, Modell B. March of Dimes Global Report on Birth Defects: the hidden toll of dying and disabled children. March of Dimes Birth Defects Foundation. White Plains, New York: March of Dimes, 2006.
Christianson AL, Modell BM. Medical genetics in developing countries. Annu Rev Genomics Hum Genet 2004; 5: 219–265. [Available on-line at http://www.annualreviews.org].
Christianson A, Zimmern R. Health Needs Assessment for medical genetic services in middle- and low-income nations. http://www.capabilitynet.eu/. 2009.
Donnabedian A. An introduction to quality assurance in health care. New York: Oxford University Press Inc, 2003.
Heredero L. Comprehensive national genetic program in a developing country- Cuba. Birth Defects Orig Artic Ser 1992; 28: 52–57.
Jordan J, Dowswell T, Harrison S, Lilford R, Mort M. Whose priority? Listening to users and the public. Br Med J 1998; 316: 1668–1670.
McKusick VA. The growth and development of human genetics as a clinical discipline. Am J Hum Genet 1975; 27: 261–273.
NICE: Health needs assessment: A practical guide. National Institute for Health & Clinical Excellence. http://www.nice.org.uk/media/150/35/Health_Needs_Assessment_A_Practical_Guide.pdf. (Accessed 19th April 2009). 2005.
Silvey K, Newell A. Oregon’s Strategic Plan for Genetics and Public Health. Oregon Department of Human Services. [http://www.oregon.gov/DHS/ph/genetics/docs/orplan03.pdf] (Accessed 2nd May 2009). 2002.
Smith P, Haggard S. Planning for a single speciality in a Health District. J Oper Res Soc 1982; 33: 29–39.
Stevens A, Gillam S. Needs assessment: from theory to practice. Br Med J 1998; 316: 1448–1452.
Stevens A, Mant J, Raftery J, Simpson S. Health Care Needs Assessment. The Epidemiological Based Needs Assessment Reviews. Vol 1. 2nd edn. UK: Radcliffe Publishing, 2004.
WHO. Human genetics and public health. Technical report series No. 282. Geneva, Switzerland: World Health Organization, 1964.
WHO. Community approaches to the control of hereditary diseases. Report of an advisory group. Geneva, Switzerland: World Health Organization, 1985.
WHO/World Alliance for the Prevention of Birth Defects. Services for the prevention and management of genetic disorders and birth defects in developing countries. Geneva, Switzerland: World Health Organization, 1999.
WHO. Primary health care approaches for prevention and control of congenital and genetic disorders. Geneva, Switzerland: World Health Organization, 2000.
WHO. Birth Defects. Report by the Secretariat for the 125th session of the Executive Board. Geneva, Switzerland: World Health Organization, 2009. [http://www.who.int/gb/ebwha/pdf_files/EB125_7-en.pdf] (Accessed 11th June 2009).
Wright J, Williams R, Wilkinson JR. Development and importance of health needs assessment. Br Med J 1998; 316: 1310–1313.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Christianson, A., Zimmern, R.L. (2010). Assuring Quality When Establishing Medical Genetic Services in Middle- and Low-Income Nations. In: Kristoffersson, U., Schmidtke, J., Cassiman, J. (eds) Quality Issues in Clinical Genetic Services. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-3919-4_14
Download citation
DOI: https://doi.org/10.1007/978-90-481-3919-4_14
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-3918-7
Online ISBN: 978-90-481-3919-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)